Xiaofeng Tan

668 total citations
38 papers, 479 citations indexed

About

Xiaofeng Tan is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Xiaofeng Tan has authored 38 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Biomedical Engineering, 14 papers in Materials Chemistry and 12 papers in Molecular Biology. Recurrent topics in Xiaofeng Tan's work include Nanoplatforms for cancer theranostics (21 papers), Photodynamic Therapy Research Studies (8 papers) and Luminescence and Fluorescent Materials (8 papers). Xiaofeng Tan is often cited by papers focused on Nanoplatforms for cancer theranostics (21 papers), Photodynamic Therapy Research Studies (8 papers) and Luminescence and Fluorescent Materials (8 papers). Xiaofeng Tan collaborates with scholars based in China, Lithuania and Ukraine. Xiaofeng Tan's co-authors include Qinglai Yang, Gui‐long Wu, Sha Yang, Li Tang, Na Li, Peixian Wu, Fen Liu, Wei Zhou, Hao Xiao and Minghui Wang and has published in prestigious journals such as Biomaterials, Analytical Chemistry and Chemical Engineering Journal.

In The Last Decade

Xiaofeng Tan

36 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Tan China 14 277 206 129 85 75 38 479
Yijian Gao China 13 410 1.5× 319 1.5× 120 0.9× 66 0.8× 84 1.1× 36 632
Changchang Teng China 13 349 1.3× 301 1.5× 62 0.5× 58 0.7× 67 0.9× 22 493
Xue Qiao China 6 436 1.6× 370 1.8× 125 1.0× 44 0.5× 67 0.9× 7 566
Jiantao Ping China 11 165 0.6× 125 0.6× 119 0.9× 45 0.5× 51 0.7× 26 331
Youliang Tian China 13 364 1.3× 310 1.5× 69 0.5× 35 0.4× 93 1.2× 18 446
Takaaki Uno Japan 6 412 1.5× 285 1.4× 94 0.7× 40 0.5× 69 0.9× 9 558
Huiping Dang China 12 330 1.2× 292 1.4× 53 0.4× 36 0.4× 67 0.9× 17 397
Shibo Lv China 10 299 1.1× 289 1.4× 47 0.4× 45 0.5× 68 0.9× 19 450
Changli Zhang China 6 273 1.0× 193 0.9× 61 0.5× 43 0.5× 37 0.5× 13 361
Te‐Haw Wu Taiwan 11 261 0.9× 437 2.1× 174 1.3× 78 0.9× 63 0.8× 19 623

Countries citing papers authored by Xiaofeng Tan

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Tan more than expected).

Fields of papers citing papers by Xiaofeng Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Tan. The network helps show where Xiaofeng Tan may publish in the future.

Co-authorship network of co-authors of Xiaofeng Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Tan. A scholar is included among the top collaborators of Xiaofeng Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Tan. Xiaofeng Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Jian, Baoliang Zhao, Chuanfu Li, et al.. (2025). Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma. Materials Today Bio. 30. 101442–101442. 1 indexed citations
2.
Tan, Xiaofeng, Ying Li, Jin Hao, et al.. (2025). Metformin-induced precise targeted inhibition of ischemic neuronal death by a programable endogenous ROS-responsive nanoprodrug. Chemical Engineering Journal. 512. 162106–162106.
3.
4.
Kang, Qiang, Fen Liu, Zelong Li, et al.. (2025). Molecular Engineering of NIR-II Excitable Phototheranostic for Mitochondria-Targeted Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. 68(7). 7707–7719. 2 indexed citations
5.
Tan, Xiaofeng, et al.. (2025). Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma. Frontiers in Pharmacology. 16. 1540636–1540636.
6.
Wang, Minghui, Hongyu Gong, Na Li, et al.. (2024). Immobilizing DNase in ternary AuAgCu hydrogels to accelerate biofilm disruption for synergistically enhanced therapy of MRSA infections. International Journal of Biological Macromolecules. 277(Pt 4). 134518–134518. 2 indexed citations
7.
Wu, Juan, Xiaofeng Tan, Yu Liu, et al.. (2024). NIR-activated water-soluble molecular probe based on Cu(ii) ion quenching mechanisms and substituted strategies: For in vitro/in vivo H2S detection. Sensors and Actuators B Chemical. 415. 135875–135875. 4 indexed citations
8.
Wang, Minghui, Na Li, Yingying Wu, et al.. (2024). Norepinephrine-induced hydrophilic Pd aerogels with photothermal-boosted multienzyme-like activity for chemodynamic therapy of MRSA infections. Chemical Engineering Journal. 484. 149447–149447. 13 indexed citations
9.
Wu, Gui‐long, et al.. (2024). Recent advances in ferrocene-based nanomedicines for enhanced chemodynamic therapy. Theranostics. 15(2). 384–407. 8 indexed citations
10.
Yang, Sha, Hao Xiao, Qiang Kang, et al.. (2024). Lysosome-Targeted and pH-Activatable Phototheranostics for NIR-II Fluorescence Imaging-Guided Nasopharyngeal Carcinoma Phototherapy. Bioconjugate Chemistry. 35(7). 1015–1023. 8 indexed citations
11.
Fan, Zhongxiong, Xiaofeng Tan, Ying Li, et al.. (2023). ROS-responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson’s disease therapy. Chemical Engineering Journal. 466. 143245–143245. 11 indexed citations
12.
Wu, Gui‐long, Fen Liu, Na Li, et al.. (2023). Trisulfide Bond‐Mediated Molecular Phototheranostic Platform for “Activatable” NIR‐II Imaging‐Guided Enhanced Gas/Chemo‐Hypothermal Photothermal Therapy. Advanced Science. 10(36). e2304104–e2304104. 48 indexed citations
13.
Pan, Qi, Ke Li, Yafei Wang, et al.. (2023). Rational design of NIR-II molecule-engineered nanoplatform for preoperative downstaging and imaging-guided surgery of orthotopic hepatic tumor. Journal of Nanobiotechnology. 21(1). 489–489. 4 indexed citations
14.
Wu, Gui‐long, Xiaofeng Tan, & Qinglai Yang. (2023). Recent Advances on NIR‐II Light‐Enhanced Chemodynamic Therapy. Advanced Healthcare Materials. 13(10). e2303451–e2303451. 25 indexed citations
15.
Fan, Zhongxiong, Tong Ren, Youjun Wang, et al.. (2022). Aβ-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer's disease via enhancing microglial Aβ clearance. Biomaterials. 283. 121452–121452. 32 indexed citations
16.
Yang, Sha, Gui‐long Wu, Na Li, et al.. (2022). A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy. Journal of Nanobiotechnology. 20(1). 475–475. 38 indexed citations
17.
Maggiore, Antonio, Xiaofeng Tan, Arnaud Brosseau, et al.. (2022). Novel D–A chromophores with condensed 1,2,4-triazine system simultaneously display thermally activated delayed fluorescence and crystallization-induced phosphorescence. Physical Chemistry Chemical Physics. 24(29). 17770–17781. 15 indexed citations
18.
Yang, Sha, Na Li, Hao Xiao, et al.. (2022). Clearance pathways of near-infrared-II contrast agents. Theranostics. 12(18). 7853–7883. 18 indexed citations
19.
Yang, Sha, Xiaofeng Tan, Li Tang, & Qinglai Yang. (2021). Near-Infrared-II Bioimaging for in Vivo Quantitative Analysis. Frontiers in Chemistry. 9. 763495–763495. 12 indexed citations
20.
Bezvikonnyi, Oleksandr, Rasa Keruckienė, Dmytro Volyniuk, et al.. (2021). Multifunctional derivatives of pyrimidine-5-carbonitrile and differently substituted carbazoles for doping-free sky-blue OLEDs and luminescent sensors of oxygen. Journal of Advanced Research. 33. 41–51. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026